A Study of NBL-012 in Healthy Chinese Subjects

Clinical trial NCT05259189 · COMPLETED

Trial details

NCT number: NCT05259189
Sponsor: NovaRock Biotherapeutics, Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2021-07-01
Primary completion: 2022-05-23
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.